FANCG and CYP19A1

Number of citations of the paper that reports this interaction (PubMedID 11756225)
42

Data Source:
HPRD (in vitro)

		FANCG	CYP19A1
Description		FA complementation group G	cytochrome P450 family 19 subfamily A member 1
Image		No pdb structure
GO Annotations	Cellular Component	Nucleoplasm Nucleolus Mitochondrion Cytosol Plasma Membrane Fanconi Anaemia Nuclear Complex	Endoplasmic Reticulum Endoplasmic Reticulum Membrane Membrane Integral Component Of Membrane
	Molecular Function	Damaged DNA Binding Protein Binding	Iron Ion Binding Steroid Hydroxylase Activity Electron Transfer Activity Oxidoreductase Activity, Acting On Paired Donors, With Incorporation Or Reduction Of Molecular Oxygen, Reduced Flavin Or Flavoprotein As One Donor, And Incorporation Of One Atom Of Oxygen Oxygen Binding Heme Binding Aromatase Activity
	Biological Process	Ovarian Follicle Development DNA Repair Cellular Response To DNA Damage Stimulus Mitochondrion Organization Spermatid Development Response To Radiation Interstrand Cross-link Repair	Steroid Biosynthetic Process Estrogen Biosynthetic Process Androgen Catabolic Process Female Gonad Development Sterol Metabolic Process Electron Transport Chain Response To Estradiol Positive Regulation Of Estradiol Secretion
Pathways		Fanconi Anemia Pathway	Estrogen biosynthesis Endogenous sterols Defective CYP19A1 causes AEXS
Drugs			Nicotine Aminoglutethimide Estrone Testolactone Exemestane Letrozole Anastrozole 2-Methoxyestradiol Naringenin Glyphosate MPI-674
Diseases
GWAS		Mean reticulocyte volume ( 32888494) Mean spheric corpuscular volume ( 32888494) Platelet count ( 32888494)	Airway wall thickness ( 25517131) Aspartate aminotransferase levels ( 33547301) Breast cancer ( 31757997) Cerebrospinal fluid AB1-42 levels ( 20932310) Endometrial cancer ( 30093612 27135401) Endometrial cancer (endometrioid histology) ( 30093612) Endometrial endometrioid carcinoma ( 27135401) Estradiol levels ( 22675492 29325096 34255042) Estrone levels ( 29325096) Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer ( 28429243) Follicle stimulating hormone levels ( 24049095) Heel bone mineral density ( 30598549 28869591) Height ( 20881960 25282103 25429064 31562340 23456168 33713608 20189936) Hip circumference adjusted for BMI ( 34021172) Hip index ( 34021172) Hormone measurements ( 24049095) Liver enzyme levels (alkaline phosphatase) ( 33972514) Lymphocyte percentage of white cells ( 32888494) Menarche (age at onset) ( 23599027) Neutrophil percentage of white cells ( 32888494) Response to fenofibrate (HDL cholesterol levels) ( 27002377) Reticulocyte count ( 32888494) Serum alkaline phosphatase levels ( 33547301 29403010) Thiazide-induced adverse metabolic effects in hypertensive patients ( 23400010) Total body bone mineral density ( 29304378) Waist circumference adjusted for body mass index ( 34021172) Waist-hip index ( 34021172) Waist-to-hip ratio adjusted for BMI ( 34021172)
Interacting Genes		44 interacting genes: BRCA2 BRCC3 CAPN1 CBY2 CDK1 COG6 CTBP1 CYP19A1 CYP2E1 DOK5 ERCC4 FANCA FANCC FANCE FANCF FTSJ3 GABPB1 GATA1 GOLGA2 HES1 HGS IHO1 IKZF3 KRT13 KRT19 LNX2 MEOX2 NECAB2 NLGN3 PSMB1 RINT1 RTN2 SAMD3 SSX2IP TADA2A TCEANC TFIP11 TLE5 TPRX1 UIMC1 USHBP1 XRCC3 ZBED1 ZBTB1	2 interacting genes: CRBN FANCG
Entrez ID		2189	1588
HPRD ID		04262	00488
Ensembl ID		ENSG00000221829	ENSG00000137869
Uniprot IDs		O15287 Q53XM5	A0A024R5S8 A8K6W3 P11511 Q05CU4 Q8IYG4 Q8TCA4
PDB IDs			1TQA 3EQM 3S79 3S7S 4GL5 4GL7 4KQ8 5JKV 5JKW 5JL6 5JL7 5JL9
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?